Item
Coll de Tuero, Gabriel | |
2018 June 5 | |
Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies | |
http://hdl.handle.net/2072/320122 | |
eng | |
Editorial Glosa | |
Tots els drets reservats | |
Hipertensió
Hypertension Alzheimer, Malaltia d’ -- Tractament Alzheimer’s disease -- Treatment |
|
Hipertensión arterial y enfermedad de Alzheimer | |
info:eu-repo/semantics/article | |
Recercat |